O'Shaughnessy Asset Management’s Champions Oncology CSBR Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,031	Closed	-$90K	–	2702
2025 Q4	$90K	Sell	13,031 -1,436	-10%	-$9.56K	﹤0.01%	2145
2025 Q3	$93.7K	Sell	14,467 -4,091	-22%	-$28.8K	﹤0.01%	2105
2025 Q2	$137K	Sell	18,558 -362	-2%	-$2.56K	﹤0.01%	1902
2025 Q1	$164K	Buy	+18,920	New	+$192K	﹤0.01%	1814
2021 Q2	–	Sell	-25	Closed	–	–	2591
2021 Q1	$0	Hold	25	–	–	﹤0.01%	2383
2020 Q4	$0	Buy	+25	New	+$258	﹤0.01%	2095

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

O'Shaughnessy Asset Management's CSBR Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of Champions Oncology (CSBR) in Q1 2026, closing a stake of 13,031 shares — an estimated $90K sold.

O'Shaughnessy Asset Management first reported a position in CSBR in Q4 2020 and held it in 6 quarters. The position peaked at $164K in Q1 2025. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

O'Shaughnessy Asset Management reported no remaining Champions Oncology position as of Q1 2026 after selling out during the quarter.
O'Shaughnessy Asset Management sold 13,031 Champions Oncology shares in Q1 2026, an estimated $90K.
O'Shaughnessy Asset Management first reported a position in Champions Oncology in Q4 2020 and held it in 6 quarters.
O'Shaughnessy Asset Management's Champions Oncology position peaked at $164K in Q1 2025.
25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.